"Answer the call to serve — start your medical and research career at LLU. We integrate health, science and faith to create a mission-focused learning environment. Explore our programs, like the Pathologists' Assistant program, and apply today. LLU has been teaching tomorrow’s healthcare professionals for more than 100 years. From six-month certificate programs, online degrees and doctorates to critical mission work abroad, students learn the tools needed to make an impact in their communities. Our six hospitals offer a safe and challenging environment for hands-on training — all guided by faculty recognized as national and worldwide leaders in health."

During the past decade, Loma Linda University School Of Medicine conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 8 clinical trials were completed, i.e. on average, 266.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Loma Linda University School Of Medicine" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Dana-Farber Cancer Institute" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Loma Linda University School Of Medicine" #1 collaborator was "NSABP Foundation Inc" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "Tuberous Sclerosis Alliance" with 1 trials as a collaborator and "Wyeth is now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Loma Linda University School Of Medicine" are "Parkinson Disease" (2 trials), "Action Tremor" (1 trials), "Alzheimer Disease" (1 trials), "Brain Infarction" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Loma Linda University School Of Medicine" in a lesser frequency.

Most popular intervention types in "Loma Linda University School Of Medicine" are "Drug" (9 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Abemaciclib" (2 trials), "ANS Totally Implantable Deep Brain Stimulation System" (1 trials), "Ancrod (Viprinex)" (1 trials) and "Duloxetine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Loma Linda University School Of Medicine" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Loma Linda University School Of Medicine". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Loma Linda University School Of Medicine, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Loma Linda University School Of Medicine, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".